Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gut-Retina-axis Study in nAMD
NCT06391411Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Careggi
- Start
- Mar 2021
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
Randomised, open-label trial (3 arms), sponsored by Azienda Ospedaliero-Universitaria Careggi. Primary endpoints: Changes in gut microbiota composition at 6 months, Changes in gut microbiota function at 6 months and 1 more. Started Mar 2021; status: completed.
Beyond the preview
Go deeper on NCT06391411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06391411.